Is Hamlet BioPharma (FRA:7ZT) In A Good Position To Invest In Growth?
Jan 03
Have your own idea? Try our Stock Screener
German (DAX) Biotech Industry Analysis
UpdatedApr 01, 2026
DataAggregated Company Financials
Companies15
- 7D2.6%
- 3M12.8%
- 1Y-2.4%
- YTDn/a
The Biotech industry is up 2.6% in the last week, with Formycon up 5.3%. During this same period, the Biomark Diagnostics underperformed, falling 15%. The industry has been flat over the past 12 months despite the gain this week. Looking forward, earnings are forecast to grow by 64% annually.
Industry Valuation and Performance
Has the German Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 02 Apr 2026 | €3.9b | €742.4m | -€199,703,235.29 | 3.7x | -19.4x | 5.2x |
| Sat, 28 Feb 2026 | €3.5b | €744.1m | -€183,580,388.35 | 4.3x | -19.1x | 4.7x |
| Mon, 26 Jan 2026 | €3.4b | €744.1m | -€183,462,611.00 | 4.1x | -18.5x | 4.6x |
| Wed, 24 Dec 2025 | €3.3b | €744.0m | -€183,306,982.16 | 3.7x | -18x | 4.4x |
| Fri, 21 Nov 2025 | €3.2b | €748.0m | -€195,495,546.05 | 3.4x | -16.6x | 4.3x |
| Sun, 19 Oct 2025 | €3.2b | €755.4m | -€211,428,043.07 | 3.5x | -15.3x | 4.3x |
| Tue, 16 Sep 2025 | €2.0b | €121.4m | -€184,122,362.26 | 3.3x | -10.8x | 16.4x |
| Thu, 14 Aug 2025 | €3.4b | €774.6m | -€184,922,260.59 | 3.5x | -18.3x | 4.4x |
| Sat, 12 Jul 2025 | €2.4b | €772.7m | -€178,999,093.00 | 3.9x | -13.2x | 3x |
| Mon, 09 Jun 2025 | €2.3b | €772.7m | -€178,999,093.00 | 4.1x | -12.9x | 3x |
| Wed, 07 May 2025 | €2.2b | €836.4m | -€143,205,717.00 | 24.2x | -15.4x | 2.6x |
| Fri, 04 Apr 2025 | €2.2b | €818.3m | -€158,085,276.00 | 29.6x | -14x | 2.7x |
| Sun, 02 Mar 2025 | €2.3b | €791.9m | €72.9m | 13.8x | 31.2x | 2.9x |
| Tue, 28 Jan 2025 | €2.7b | €791.8m | €74.2m | 14.6x | 36.6x | 3.4x |
| Thu, 26 Dec 2024 | €2.6b | €791.8m | €74.2m | 14.5x | 35.2x | 3.3x |
| Sat, 23 Nov 2024 | €2.5b | €791.8m | €74.2m | 12.9x | 34.3x | 3.2x |
| Mon, 21 Oct 2024 | €2.7b | €866.1m | €170.2m | 11.9x | 15.8x | 3.1x |
| Wed, 18 Sep 2024 | €2.6b | €867.2m | €174.8m | 12.2x | 14.9x | 3x |
| Fri, 16 Aug 2024 | €2.6b | €867.0m | €171.1m | 14.2x | 15.1x | 3x |
| Sun, 14 Jul 2024 | €2.7b | €885.2m | €215.0m | 12.8x | 12.7x | 3.1x |
| Tue, 11 Jun 2024 | €2.6b | €884.7m | €210.7m | 11.7x | 12.5x | 3x |
| Thu, 09 May 2024 | €2.6b | €884.7m | €210.7m | 9.9x | 12.1x | 2.9x |
| Sat, 06 Apr 2024 | €5.2b | €1.0b | -€179,347,058.40 | 9.1x | -29.1x | 5.2x |
| Mon, 04 Mar 2024 | €2.7b | €746.1m | -€35,822,108.00 | 12.5x | -74x | 3.6x |
| Wed, 31 Jan 2024 | €2.8b | €769.9m | -€145,885,802.00 | 13x | -19.1x | 3.6x |
| Fri, 29 Dec 2023 | €2.9b | €779.7m | -€160,010,802.00 | 13.6x | -17.8x | 3.7x |
| Sun, 26 Nov 2023 | €2.9b | €779.7m | -€160,010,802.00 | 13.6x | -18.1x | 3.7x |
| Tue, 24 Oct 2023 | €3.6b | €955.3m | -€172,995,145.00 | 10x | -21x | 3.8x |
| Thu, 21 Sep 2023 | €4.0b | €971.6m | -€197,588,171.00 | 11.6x | -20.2x | 4.1x |
| Sat, 19 Aug 2023 | €4.0b | €947.8m | -€36,632,772.00 | 19x | -109.8x | 4.2x |
| Mon, 17 Jul 2023 | €4.0b | €955.7m | -€219,213,323.00 | 26.2x | -18.2x | 4.2x |
| Wed, 14 Jun 2023 | €4.1b | €967.4m | -€212,660,026.00 | 30.2x | -19.4x | 4.3x |
| Fri, 12 May 2023 | €3.7b | €967.4m | -€209,726,026.00 | 29.9x | -17.6x | 3.8x |
| Sun, 09 Apr 2023 | €3.5b | €920.1m | -€215,175,409.00 | 13.6x | -16.5x | 3.9x |
Price to Earnings Ratio
-16.5x
Current Industry PE
- Investors are optimistic on the German Biotechnology industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.0x is lower than the industry's current PS ratio of 5.2x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 6.9% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Comparison
How does German Biotech compare with similar industries?
| DE Market | 0.20% | |
| Healthcare | 1.67% | |
| Biotech | 2.57% | |
| Biotech | 2.57% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 7ZT Hamlet BioPharma | €0.78 | 17.5% +€21.4m | n/a | PS7554.1x | |
| FYB Formycon | €18.96 | 2.2% +€7.1m | -19.5% | PS7x | |
| HF00 Respiratorius | €0.10 | 5.9% +€45.0k | -79.7% | PB0.3x | |
| CNW co.don | €0.015 | 11.1% +€40.1k | 20.0% | n/a | |
| 8V8 Genetic Analysis | €0.035 | 1.4% +€34.5k | -19.3% | PS1.3x |